Is Eltrombopag included in medical insurance?
Eltrombopag (Eltrombopag) is an oral, non-peptide thrombopoietin receptor agonist that increases platelet count primarily by stimulating the proliferation and differentiation of megakaryocytes. This mechanism makes eltrombopag highly effective in the treatment of chronic immune thrombocytopenic purpura (ITP). Especially for patients who have poor response to traditional treatments such as glucocorticoids and immunoglobulins, eltrombopag provides a new treatment option.
Usually after taking this drug for 1-2 weeks, the platelet level in the patient's body begins to gradually increase, showing the therapeutic effect. In addition to ITP, eltrombopag is also used to treat severe aplastic anemia, showing its potential in improving hematopoietic function.

In terms of taking method, it is recommended to take it on an empty stomach or between meals, and the tablet needs to be swallowed whole to ensure the best efficacy. At the same time, avoid taking it with certain drugs or foods to prevent absorption.
Eltrombopag is now available in China and has been included in the national medical insurance reimbursement catalog. The specifications of the original research drug on the market are 25 mg and 28 tablets, and the price after medical insurance reimbursement is about 2,700 to 4,500 yuan. For specific price information, please contact the local medical insurance bureau. It is also understood that the version of eltrombopag produced by Novartis in Switzerland and available in Turkey and India is 50mg 14 tablets, with a price of about 2,800 yuan per box. At the same time, there are a variety of generic drugs of eltrombopag available in overseas markets, most of which cost around 500-1,200 yuan. Patients can choose the appropriate product according to their own needs. If you need to know more about eltrombopag, please consult a regular overseas medical consulting service organization.
Although eltrombopag is effective, it may also cause some side effects, such as headache, nausea, etc. Therefore, you should follow your doctor's advice when using it and pay close attention to your body's reaction. Overall, eltrombopag offers new treatment avenues and hope for patients with thrombocytopenia.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)